• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDCAD ACCUPLAN; INTERMEDIATE SPLINT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDCAD ACCUPLAN; INTERMEDIATE SPLINT Back to Search Results
Catalog Number MC-K001
Device Problem Unexpected Therapeutic Results (1631)
Patient Problem Physical Asymmetry (4573)
Event Date 04/20/2021
Event Type  malfunction  
Manufacturer Narrative
On april 20, 2021 medcad was informed by complainant via text messages and phone call regarding an alleged malfunction relating to the intermediate splints used in case (b)(4) hod.The splint in question was placed into occlusion during surgery and was observed to promote minimal advancements on the right lefort segment and the left segment showed a 6mm advancement.These unintended advancements seemed to "mirror" what was presented in the surgical plan.The final splints that were supplied were not used in the surgery.The doctor who performed the surgery for this case, indicated that "the patient looks good" after a one-week patient follow-up, in an in-person conversation with the customer services manager on (b)(6) 2021.Attempts to collect information, such as the patient's weight at the time of surgery and whether the surgery was prolonged, were made during this conversation but was not provided.Surgeon approval for the splint design was confirmed on (b)(6) 2021.Device history record review of case (b)(4) hod identified no non-conformances related to the production of the device in question and was manufactured according to medcad's production requirements.Inspection of the device was performed on (b)(6) 2021 and passed fit inspection against patient-specific dental models.Conclusion of this investigation found no clear root-cause for this alleged malfunction.
 
Event Description
The maxillary and mandibular advancements that were called out in the orthognathic digital surgical plan (dsp), were not reflective of what was observed during the surgery when the intermediate splints were used.The orthognathic dsp called for 6.1mm advancement on the pt.Right lefort segment and 0.8mm advancement on the pt.Left leftort segment, but when the intermediate splints were placed into occlusion during surgery, the maxillary advancements were observed to be the opposite of the plan's intended advancements.Similarly, the mandibular advancements were observed to be the opposite as what was called out in the orthognathic dsp.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUPLAN
Type of Device
INTERMEDIATE SPLINT
Manufacturer (Section D)
MEDCAD
501 south second ave
suite a1000
dallas TX 75226
Manufacturer (Section G)
MEDCAD
501 south second ave
suite a1000
dallas TX 75226
Manufacturer Contact
james allo
501 south second ave
suite a1000
dallas, TX 75226
MDR Report Key11849419
MDR Text Key251449452
Report Number3009196021-2021-00004
Device Sequence Number1
Product Code NDP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMC-K001
Device Lot Number215631 HOD
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/20/2021
Initial Date FDA Received05/19/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/12/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age29 YR
-
-